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Carsten Werner1 & Tilo Pompe1,4
Homeostasis of hematopoietic stem cells (HSC) in the mammalian bone marrow stem cell niche is 
regulated by signals of the local microenvironment. Besides juxtacrine, endocrine and metabolic cues, 
paracrine and autocrine signals are involved in controlling quiescence, proliferation and differentiation of 
HSC with strong implications on expansion and differentiation ex vivo as well as in vivo transplantation. 
Towards this aim, a cell culture analysis on a polymer microcavity carrier platform was combined with 
a partial least square analysis of a mechanistic model of cell proliferation. We could demonstrate the 
discrimination of specific autocrine and paracrine signals from soluble factors as stimulating and inhibitory 
effectors in hematopoietic stem and progenitor cell culture. From that we hypothesize autocrine signals 
to be predominantly involved in maintaining the quiescent state of HSC in single-cell niches and advocate 
our analysis platform as an unprecedented option for untangling convoluted signaling mechanisms in 
complex cell systems being it of juxtacrine, paracrine or autocrine origin.
Hematopoietic stem cells (HSCs) continuously generate mature blood cells to renew or maintain life-long 
hematopoiesis. The dynamic regulation of HSC number and progeny involves complex signaling mechanisms, 
which are strongly influenced by the local microenvironment. The urgent need for a better understanding of HSC 
regulation is motivated by their fundamental role in the life-long hematopoiesis and their marked regenerative 
potential after transplantation in clinical therapies of several diseases such as cancer or autoimmune disorders1,2. 
Failure of host engraftment, limited regeneration of the host hematopoietic system as well as challenges associ-
ated with ex vivo expansion strategies limit the success of HSC-based therapies and ask for an increased knowl-
edge on HSC signaling3,4. In addition to juxtacrine signals from neighboring stromal cells and the extracellular 
matrix (ECM), a number of autocrine and paracrine signals from soluble mediator molecules have been shown to 
influence hematopoiesis by regulating proliferation and quiescence, as well as self-renewal and differentiation5–7. 
Complex interactions between these different signals are very challenging to decipher in the poorly accessible 
in vivo HSC microenvironment. Currently, a major hurdle to achieving robust ex vivo HSC expansion is the 
inability to distinguish between the autocrine and paracrine signals that govern hematopoiesis. For example sig-
naling from VEGF via an internal autocrine loop has been shown to regulate HSC survival8. Notably increased 
expression levels of VEGF and receptors have been found in human hematopoietic tumor cell lines and there is 
evidence that internal and external autocrine VEGF loops regulate leukemia survival9,10. However even though 
other factors, e.g. FLT3L and TGF-β , have been shown to control hematopoiesis via autocrine loops as well, the 
autocrine or paracrine origin of most factors remains an open issue hindering current culture strategies to specif-
ically control their supporting or adverse impact of HSC maintenance and expansion in vitro11,12.
A promising strategy to increase HSC expansion ex vivo is mimicking the HSC microenvironment by the inte-
gration of bioengineering approaches with our constantly expanding knowledge of the soluble signals involved 
in hematopoiesis13,14. For instance, growth factors, regulatory cytokines and chemokines essential for the tightly 
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balanced intercellular crosstalk regulating HSC fate have been successfully identified using protein microarray 
technologies15–17. The presentation of these signals in an HSC culture system can be precisely controlled using 
biomaterial scaffolds. In fact, biomaterial scaffolds have already been designed to precisely control the presenta-
tion of growth factors (e.g., stem cell factor (SCF), stromal cell-derived factor 1 (SDF1)18,19, cell surface ligands 
(e.g., cadherins, Jagged1)20,21, ECM components (e.g., fibronectin (FN), heparan sulfate)22 and topographical fea-
tures23,24 to recapitulate the bone marrow (BM) microenvironment in vitro. These modular toolboxes along with 
in-depth in vitro analysis provide tools to facilitate the understanding of autocrine and paracrine signaling in 
HSC regulation.
In the present study, we develop and use a microcavity platform to contribute to the deciphering of autocrine 
and paracrine signals in HSC fate regulation. Motivated by previous work of Csaszar E et al.25 we focused on 
the role of a large set of soluble factors with prospective impact in HSC regulation, additionally asking for the 
impact of juxtacrine adhesive signals from the ECM. Using silicone and hydrogel based microcavity arrays with 
multi-cell and single-cell sized features functionalized with FN or heparin, hematopoietic stem and progenitor 
cell (HSPC) proliferation and differentiation were studied in vitro in the context of a multiplex immunoassay 
analysis of cell-secreted growth factors. Based on a mechanistic model of HSC signals, a partial least squares 
(PLS) algorithm allowed the identification of the key players in the regulation of HSPC fate in our setting26,27. The 
combination of our biofunctional microcavity platform and PLS analysis introduces a novel approach that can be 
used to identify key molecules and their signaling mechanisms in other in vitro biological systems.
Results
Biofunctional microcavity arrays. The basic premise behind the development of our microcavity plat-
form was that autocrine and paracrine signals, as well as juxtacrine cell-cell and cell-ECM signals, can be dis-
tinguished by comparing single-cell and multi-cell arrangements of HSPCs in vitro. For human HSPCs a 15 μ m 
diameter microcavity is very well suited to establish a single cell constraint, while 40 μ m diameter microcavities 
can already harbor up to 12 HSPCs (see next section). The cell-sized depth of the microcavities of 10 μ m allows to 
impose spatial constraints on the cells while still enable cells to migrate and proliferate over the microstructured 
surface24,28. We cultured HSPCs in microcavity array scaffolds, produced from either poly(dimethyl siloxane) 
silicone (PDMS), 4-arm poly(ethylene oxide) (sPEG), or biohybrid sPEG-heparin hydrogels, which allowed us to 
vary important exogenous parameters of the HSC microenvironment, namely the local cell density and material 
properties of the cell culture substrate. We omitted co-culture experiments as they drastically increase the variety 
of possible interactions and the complexity of the system limiting by that possible conclusions. Furthermore, pure 
HSPC cultures were shown to be a relevant model for HSPC studies25,29.
The microstructured PDMS system is well established for ex vivo HSC culture and we recently demonstrated 
it to maintain HSC functionality in mouse repopulation studies significantly better than standard cell culture24,30. 
PDMS microcavity arrays, with 10 μ m microcavity depth and either 15 or 40 μ m microcavity diameters, were 
produced by soft lithography. The microcavity arrays were covalently functionalized with FN, a native component 
of the HSC niche, using maleic anhydride copolymer thin films as a reactive coating (Fig. 1A)23. These scaffolds 
provide adhesion ligands for integrin mediated interactions, exhibit a high stiffness (shear modulus 2 MPa) and 
are non-penetrable for small growth factors and nutrition factors.
In contrast, the hydrogel microcavity system is based on end-functionalized sPEG crosslinked with heparin 
as a functional glycosaminoglycan31,32. Due to the physicochemical properties of the hydrogel scaffolds, namely 
highly hydrophilic and fragile, a new technology applying sacrificial polymer microstructures, patterned via 
solvent-assisted micromolding (SAMIM), was used to fabricate micro-structured hydrogel scaffolds with dense 
microcavities (Fig. 1B–D). Thereby we could create 10 μ m deep, densely hexagonal packed microcavities as small 
as 15 μ m with 3 μ m thick walls between the microcavities. These hydrogel microcavity arrays were made of either 
pure sPEG (sPEG-sPEG) or sPEG crosslinked with heparin (sPEG-HEP). The very soft hydrogel microstructures 
(storage modulus 1–8 kPa) retained their shape even after several weeks under cell culture conditions. The hep-
arin feature of the hydrogel scaffold was optionally used for covalent functionalization with adhesion-mediating 
RGD peptides. Furthermore, the heparin component is known to regulate the binding and release of various 
cytokines33,34.
In vitro culture of CD34+ HSPCs on top of microcavity arrays. To examine the effects of spatial 
constraint and material properties on HSPC expansion, 3·104 GCSF mobilized human CD34+ HSPCs, isolated 
from the peripheral blood of healthy donors (after obtained informed consent), were seeded on top of micro-
cavity arrays made from either hydrogels (sPEG-HEP and sPEG-sPEG) or PDMS. Tissue culture plastic (TCP) 
substrates served as controls. The cultures were supplemented with SCF, TPO and FLT3L at 10 ng·mL−1, the min-
imum concentration known to maintain or stimulate mild proliferation of HSPC over 7 days24. The low cytokine 
concentrations were chosen to avoid a very high proliferation reported at higher concentrations which could 
override the subtle influences exerted by our microarray’s spatial constraint and material properties24,35.
Over a 7 day culture period, HPSC number declined on all surfaces except for 40 μ m diameter hydrogel micro-
cavities (Fig. 2B and SI, Fig. S1C). The lowest HSPC expansion was observed on PDMS-FN scaffolds, regardless of 
microcavity diameter. The presence of heparin in hydrogel scaffolds had no apparent effect on HPSC expansion. 
Notably, although cell growth was affected by the scaffold material, the impact of microcavity size was similar 
for all three materials. Cell numbers were always significantly lower on 15 μ m microcavity arrays containing 
individual cells than on multi-cell 40 μ m microcavity arrays. Figure 2A proves the characteristics of the 15 μ m 
(single-cell) microcavities to harbor only single cells, while 40 μ m (multi-cell) microcavities contain up to 12 cells.
While increasing the concentration of supplementary cytokines (SCF, TPO, FLT3L) in the culture medium 
beyond physiological concentrations (30 ng·mL−1) did yield cytokine-driven HSPC proliferation, it did not appear 
to influence the differential impact of microcavity size and material properties on cell expansion (SI, Fig. S1C). 
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Similarly, decreasing the initial cell number to 1.5·104 cells per surface did not influence microcavity-dependent 
cell expansion (SI, Fig. S1A). Based on these observations, we conclude that the total microcavity surface was 
large enough that we never observed a complete occupation of all the microcavities on a scaffold. The final cell 
number was always lower than the maximum cell number capacity of the microcavity arrays (i.e. 3.3·105 for 15 μ 
m microcavity arrays and 7.2·105 for 40 μ m microcavity arrays).
Whereas the scaffold material and microcavity diameter were found to affect proliferation, the expression 
frequency of stem cell surface markers CD133 and CD34 was similar in all our culture conditions with 64 to 76% 
CD34+ HSPCs (Fig. 2C). Thus, the highest total number of CD133+ /CD34+ HSPCs was achieved on the hydro-
gel microcavity arrays after a 7-day culture period (Fig. 2B,C).
The use of CD34 and CD133 as markers of a HSPC subset with enriched repopulating capacity is motivated 
by its known clinical relevance and previous studies36,37. It has to be kept in mind, that the CD34+ /CD133+ 
subpopulation is not a pure HSC population, but only enriched for primitive blood progenitors. However, only 
xenotransplantation studies would allow for more relevant insights in the subpopulation characteristics, which is 
beyond the scope of this screening study. Furthermore, the impact of spatial constraints of PDMS-FN microar-
rays on HSPC in the murine model have been previously described by us including clonogenicty, proliferation, 
and in vivo transplantation demonstrating the relevance of HSPC proliferation and surface marker studies30.
Although HSPC proliferated differently in respect to material parameters (Fig. 2E), the frequency different 
subpopulations derived from the starting CD34+ selected cells appeared to be consistent between different treat-
ment conditions (Fig. 2B,C). These results suggest that the signals controlled by the microarray configurations 
mainly impact HSPC cell division rates and not lineage bias.
To determine the regulatory signals involved in HSPC cell-cell communication via soluble cell-secreted fac-
tors we analyzed a large set of secreted signaling molecules after 7 days of culture. Using multiplex immunoassays, 
we detected significant levels of the following factors involved in HSPC fate decisions: IL838, IL1239, ANG-240,41, 
GM-CSF42, HGF43,44, FST45, MIP-1β 25, PDGF-AB/BB45, PECAM-146, RANTES47, TGF-β 148, and VEGF8 (SI, Fig. S2). 
Factor levels were normalized to corresponding cell numbers at day 7 of culture. The highest factor concentra-
tions per cell were measured for ANG-2, HGF, RANTES, TGF-β 1, and VEGF (SI, Fig. S3). We observed that the 
secreted factor quantities (per cell) had a trend to be higher in the 15 μ m microcavity arrays compared to the 40 μm 
microcavity arrays. This effect was found to be independent of scaffold material and secreted factor (Fig. 2E and 
SI, Fig. S3). Furthermore, we discovered that general levels of most of the secreted factors were related to the 
Figure 1. Biofunctional microcavity arrays. (A) Confocal laser scanning microscopy (CLSM) image of a 
PDMS microcavity array (Ø: 40 μ m) functionalized with fluorophore-labeled FN (green) (left). Scale bar: 50 μ m. 
Surface chemistry used for covalent immobilization of FN (right). (B) Schematic representation of the hydrogel 
micropatterning concept. (C) 3D image of polystyrene pillar microarray (Ø: 15 μ m, h: 10 μ m) derived by 
SAMIM and imaged by multi-pinhole microscopy. (D) CLSM images of sPEG-heparin hydrogel microarrays 
of hexagonal packed cavities with diameters of 15 μ m (left) or 40 μ m (right) labeled with Alexa633 fluorophore 
(red). Scale bars: 40 μ m.
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heparin content of the scaffold material irrespective of cavity size, while a minor fraction of other factors were 
not, see Fig. 2D and Fig. S5. With the exception of IL12, ANG-2, TGF-β 1 and VEGF, measured factor levels per 
cell were always lower on microcavity arrays containing heparin in comparison to scaffolds without heparin 
(including TCP controls).
Overall, the above results suggest a complex interplay between impacts of microcavity size, scaffold material, 
and secreted factors in HSPC maintenance.
A mechanistic approach to reveal key parameters of in vitro HSPC culture. While it is clear that 
there is a relationship between microcavity size, scaffold material, and secreted signals on HSPC expansion, 
our results are difficult to interpret due to the limited information available about the synergistic interplay of 
the detected factors, the concentration levels for bioactivity, degradation rate via receptor internalization, and 
enzymes and their role in HSPC fate decisions.
In order to reveal essential information on HSPC signaling affected by environmental parameters in the con-
text of HSC maintenance and proliferation, we setup a simple mechanistic model describing HSPC expansion in 
terms of the interplay between autocrine, paracrine and juxtacrine signals mimicked by our microcavity platform 
(Fig. 3). This model comprises the following components: (1) We hypothesized that the influence of autocrine and 
paracrine signaling activity of secreted factors can be estimated by their inhibitory or stimulatory effects on cell 
number, while autocrine and paracrine activity is attenuated or amplified with increasing microcavity size. Hence, 
we considered autocrine signaling to be strongest in microcavities hosting individual cells, as they do not have any 
adjacent cells. In contrast, the level of paracrine signaling is considered to increase with higher numbers of cells 
contained in a microcavity. (2) Juxtacrine signals between cells were defined as a cell-cell contact parameter, cal-
culated on the basis of hexagonal packing and an average occupation of the large cavities by 9 of 12 maximal pos-
sible cells. Juxtacrine signals from precoated or cell-secreted adhesion ligands were treated as the same parameter 
in a reciprocal manner given that cells are expected to have more cell-ECM contacts in small microcavities allow-
ing for bottom and side contacts. Cell-ECM interactions were considered strong for FN-coated PDMS, intermedi-
ate for adhesive TCP surfaces and negligible for PEG-containing hydrogels. Lastly, heparin content of the scaffold 
was included as a sequestering parameter implying that secreted factors in the medium with heparin-affinity 
may be absorbed from the medium into the bulk volume of the hydrogel scaffold33,34. We deliberately limited the 
model to linear influences of the described signals. High-order terms and interdependencies would overstretch 
the validity and possible conclusions of the model.
The highly complex parameter set based on the experimental data and the introduced model was evaluated 
using a PLS algorithm, as such methods have been found useful to analyze high-dimensional data, especially if 
variables n are much larger than measured parameters p. Within the PLS algorithm, we applied a nonlinear iter-
ative partial least squares fitting algorithm (NIPALS) to calculate the coefficient values of our mechanistic model 
Figure 2. HSPC expansion and growth factor expression of CD34+ HSPCs cultured on top of microcavity 
arrays. (A) HSPCs cultivated for 2 days on top of hydrogel microcavity arrays with cavities of 15 (top) and 40 μ m 
(bottom) diameters. The phase contrast microscopy images prove the 15 μ m microcavities to be single-cell cavities, 
while the 40 μ m microcavities contain multiple cells (up to 12) (scale bar: 80 μ m). (B) Overall cell number of HSPCs 
cultured for 1 week on top of TCP and microcavity arrays consisting of FN functionalized PDMS, sPEG-heparin and 
sPEG hydrogel scaffolds, grown at cytokine background level of 10 ng·mL−1. All data are presented as mean ± SD 
from one donor with n = 2–3 microcavity samples per donor. Statistical significance is denoted as follows: * P < 0.05, 
* * P < 0.01, * * * P < 0.001. (C) Percentage of cells expressing CD34 and CD133 in the total cell population. All data 
are presented as mean ± SD from one donor with n = 2–3 samples per condition. (D) Plot shows the influence of 
heparin content of the microcavity arrays on growth factor levels within the cell culture supernatants exemplarily 
shown for sequestered (HGF) and non-sequestered (IL12) cytokines. Results are presented as mean ± SD from 3 
donors with n = 2–3 microcavity arrays per condition and donor. (E) Growth factor levels were measured in the 
supernatant of day 7 of culture using multiplex analysis. Plot shows measured growth factor levels normalized with 
the final cell number. Exemplary factors are presented as mean ± SD from either 1 donor (sPEG-sPEG), 2 donors 
(PDMS-FN), or 4 donors (sPEG-HEP/TCP) with n = 2–3 samples per condition and donor.
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and the impact of the x variables on their explanation of the y response, by calculating the variable importance 
(VIP) value of each variable27,49–51.
As shown in Fig. 4A the predicted cell numbers determined from the PLS calculated model coefficients fit 
almost all the experimentally obtained cell numbers. Reducing the dimension of the formula to variables having 
VIP ≥ 0.8, typically used in PLS analysis as the limit in significance, we again could nicely predict the cell num-
bers with high accuracy (R2 = 0.95)52. To validate the VIP optimized model, we applied the simplified formula 
to predict the cell number results obtained in a different experiment supplemented with 30 ng·mL−1 background 
cytokines (SCF, TPO, FLT3L) instead of 10 ng·mL−1. Although we obtained a linear relationship between the 
predicted and measured cell numbers again (Fig. 4A (right)), the accuracy was lower (R2 = 0.61). The slope of the 
linear regression calculated by the 10 ng·mL−1 model was about 3-fold lower leading to a 3-fold underestimation 
of cell number. This indicates that the cytokine background of SCF, TPO and FLT3L scales proliferative activity of 
HSPC independent of specific parameters of the microcavity and material environment.
To reveal the level and significance of stimulatory and inhibitory effects that each factor under investigation 
has on HSPC cell number, we plotted their model coefficients against their corresponding VIP values (Fig. 4B). 
From this, we observed that heparin plays the most important role on HSPC growth in our system because 
it has the highest positive coefficient value coinciding with the highest VIP score (VIP = 1.8). Also significant 
(VIP = 1.35), juxtacrine cell-ECM interactions (adhesion) had a negative coefficient value. Analyzing signifi-
cant autocrine and paracrine signals we found 6 factors with paracrine and 8 factors with autocrine activity 
(VIP > 0.8), with both signaling pathways having a balanced number of positive and negative factors. While for 5 
factors (IL12, ANG-2, GM-CSF, HGF VEGF) both autocrine and paracrine signals were found, one has to recog-
nize that we never found similar autocrine and paracrine activities (similar VIP and coefficients) for one factor. 
This points to distinct autocrine or paracrine signaling for the found factors. Focusing on the most important 
variables (VIP > 1.1) we recognized that there is a separation of the factors involved in autocrine (HGF, RANTES) 
and paracrine signaling (VEGF, IL12, ANG-2, GM-CSF). Autocrine signals appeared to be more significant, 
however with smaller coefficient values, than paracrine signals. This observation is schematically illustrated via 
the green and orange marked areas in Fig. 4B.
The latter finding motivated us to minimize the original model in order to reveal key parameters in HSPC reg-
ulation. We systematically rebuilt our original model using the PLS derived coefficients. We started with the three 
factors (heparin, autoHGF, and autoRANTES) that had the highest VIP scores (VIP > 1.6) and then in stepwise 
fashion added the 3 factors (1. adhesion, 2. paraVEGF+ paraIL12, and 3. paraANG2 + paraGM-CSF) with the 
next-highest VIP values (1.6 > VIP > 1.1) one factor at a time (Fig. 5).
By applying the model coefficients for heparin, autoHGF and autoRANTES, (VIP > 1.5) we observed that 
material characteristics, namely heparin content, not microcavity size, impacted cell number (Fig. 5A). The low 
influence of the autocrine signaling of HGF and RANTES on the microcavity size dependent cell growth (small 
coefficients in the model, see Fig. 4) is only seen on sPEG-sPEG, not on sPEG-HEP and PDMS-FN (Fig. 5A). 
By extending the model to include the coefficient for adhesion (VIP = 1.33), a microcavity size dependence was 
observed, but only on PDMS-FN (Fig. 5B). A significant impact of microcavity size on cell number was observed 
in all materials upon introducing model coefficients for paracrine signaling factors VEGF and IL12 (VIP = 1.32 
and VIP = 1.31, respectively) (Fig. 5C). Implementation of the remaining factors (1.1 < VIP < 1.3) resulted in 
a slight increase in the accuracy of predicted cell numbers but not in any significant refinement of the general 
trends (Fig. 5D).
Discussion
By applying a platform of biofunctional microcavity arrays, we revealed key parameters in autocrine, para-
crine and juxtacrine signaling of HSPCs. Our results reinforce the concept of using spatially defined niches, 
Figure 3. Mechanistic signaling model of HSPC in vitro culture. The linear model depicting the correlation 
between HSPC number, autocrine and paracrine signaling activity, cell-cell contacts, cell-ECM adhesion and 
heparin content of the microcavity arrays is illustrated. N: cell numbers; cx: concentrations of factor x; Ax: 
stimulative or inhibitory effect of factor x by autocrine signaling, n: cell-cell contacts (15 μ m cavities: 1, 40 μ m  
cavities: 3.6, planar: 6); Bx: stimulative or inhibitory influence of factor x by paracrine signaling, C: factor 
independent influence of cell - cell contacts; D: factor independent influence of adhesion to scaffold; a: material 
specific adhesion parameter (PDMS-FN: 1, TCP: 0.5, PEG-HEP&PEG-PEG: 0); E: stimulative or inhibitory 
effect of heparin; h: heparin content in the scaffold: (PEG-HEP: 1, PEG-PEG&PDMS-FN&TCP: 0).
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reflecting the environment inside the BM, to control stem cell quiescence and expansion over long time periods. 
We demonstrated that our microcavity array platform can be used to control microenvironmental signals that 
affect HSPC expansion. The HSPC expansion data were used to validate a newly established mechanistic model 
by a PLS approach to identify key parameters in the convoluted signaling system of HSPC regulation. By that 
we found autocrine signals in single-cell niches to be critical in HSPC quiescence. Finally, the sequestering of 
heparin-binding cytokines by the hydrogel scaffold was identified as a new tool to control HSPC maintenance.
A novel feature of our microcavity platform is that it enables the separation of autocrine and paracrine signa-
ling mechanisms of certain mediators of in vitro HSPC culture. Autocrine signals from RANTES and HGF were 
shown to have a small, but significant, effect on cell growth, while their paracrine signals were shown to be not 
relevant. The found model coefficients agree to reports on HSPC proliferation showing a supporting function of 
RANTES (in vitro exposure of HSPCs to RANTES yields increased levels of HSPC after transplantation in vivo) 
and hindering influence of HGF (diminished proliferation during in vitro HSPC expansion)25,47. Their small 
impact only on non-adhesive and non-factor binding sPEG-sPEG hydrogels is related to the strong factor deple-
tion of RANTES and HGF by heparin in sPEG-HEP hydrogels and the juxtacrine signals on adhesive PDMS-FN 
microcavity arrays24,53. It is expected that autocrine signaling is strongly affected by factor depletion via heparin 
in small microcavities due to the large nearby material surface area. This feature nicely fits the low abundance of 
HGF and RANTES in HSPC cultures on heparin-containing scaffolds correlating to their heparin affinity known 
from literature54,55. We believe that RANTES and HGF can be treated as examples of the effect of heparin-driven 
depletion of autocrine signals. Other factors involved in hematopoiesis or HSPC fate decisions16,17,40,45,56,57, not 
Figure 4. Partial least squares analysis of the mechanistic model. (A) Model coefficients and corresponding 
VIP values were calculated for the data obtained from the 7 day cultures of HSPCs on top of TCP and 
PDMS-FN, PEG-HEP, or PEG-PEG microcavity arrays using 10 ng·mL−1 background cytokines in the medium. 
The dimensions of the model were reduced by deleting all variables with variable importance in projection 
(VIP) scores < 0.8. The simplified model was compared to the standard PLS fit model concerning the obtained 
cell numbers. The simplified model with fitted coefficients was validated by application to the set of data 
obtained from similar HSPC experiments, but at 30 ng background cytokine levels. Dashed lines of both graphs 
illustrate the 90% prediction range. (B) Plot shows the calculated model coefficients for centered and scaled data 
as a function of VIP. Coefficients with small values, close to 0, and VIP scores < 0.8 have no significant influence 
on the explanation of the y-response. The abbreviations ‘auto.’ and ‘para.’ represent autocrine and paracrine 
contributions in the model, respectively.
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monitored in our experiments, are suggested to follow the same behavior concerning enhanced depletion of 
heparin-binding autocrine mediators. This assumption is supported by the high coefficient and VIP of the hep-
arin parameter. Although we currently cannot proof this interpretation by measuring the wealth of other sug-
gested soluble mediators in HSPC signaling, we would propose the heparin parameter to indirectly cover the 
non-measured autocrine signals in our model.
On the other hand, paracrine signaling cytokines IL12 and ANG-2, both not affected by adsorption to heparin 
in our measurements, contribute to a strong material independent microcavity effect. Again, the found model 
coefficients agree to reported effects in HSPC proliferation with a supporting function of IL12, mostly in a syner-
gistic manner with other factors such as SCF, and a hindering influence of ANG-2 (reduced number of functional 
HSC after in vitro exposure)7,40,56. Paracrine signaling should be more favored in large microcavities due to the 
close association of neighboring cells. Similarly, heparin depletion of paracrine signaling factors should only have 
a minor effect because of the smaller ratio of cells to material surface area. In agreement, our model predicted a 
size-dependent effect from IL12 and ANG-2 signaling, with higher cell numbers on the large microcavities.
These arguments on autocrine and paracrine signals allow us to conclude that in single-cell microcavities 
autocrine signaling is the prevalent pathway. The occurrence of single-cell HSC niches was reported from in 
vivo studies6,58,59. Furthermore, we previously demonstrated that in vitro culture of HSPCs on top of microcavity 
arrays hosting individual cells supports stem cell functionality24,30. We hypothesize that the more quiescent state 
of HSCs within the spatially constraint single-cell niche could be the result of increased autocrine and decreased 
paracrine signaling.
Remarkably, the presence of heparin in the cell culture scaffolds was found to be the most important variable 
in the PLS analysis, with the highest VIP and most positive coefficient value of our model. Systematically rebuild-
ing our model by stepwise extension with variables with decreasing VIP score, we revealed that the influence of 
heparin content is not related to microcavity size. As we measured lower factor levels in the cell culture super-
natants of heparin containing hydrogels, we expect heparin to support HSPC maintenance and proliferation by 
binding and sequestering a multitude of secreted signaling molecules. Notably, with the exception of ANG-2, all 
analyzed factors have reported heparin affinity46,54,55,60–68. We recently demonstrated that factor depletion pro-
motes HSPC growth, supporting our findings on altered HSPC cycling in the presence of heparin containing 
hydrogels25. Finally, we recognize that our model could not fully reconstruct the experimental data on HSPC pro-
liferation, see Fig. 2B, in particular for the sPEG hydrogels without heparin content. We assume that, in addition 
to the sequestering effect of heparin, other factors, not measured in our assays, can be similarly sequestered by 
hydrophobic interactions with maleimide groups also present in the pure sPEG hydrogels. This effect is currently 
not included in the model. However, it could account for the lower total cell number in the modeled data, see 
Fig. 5D.
Juxtacrine signals via cell-ECM adhesions were found to drastically reduce cycling of HSPCs correspond-
ing to previous reports24. However, cell-ECM adhesion could only partially explain the impact of microcavity 
size on HPSC expansion. Autocrine and paracrine signals act on HSPC cycling, too. Furthermore, our PLS 
Figure 5. Minimized models applying PLS coefficient values. To reveal the impact of autocrine and 
paracrine signaling, as well as material characteristics, we minimized the PLS derived model (VIP > 1.1) and 
systematically rebuilt it starting with the factors that had the highest VIP scores. Plots (A–D) show the predicted 
cell numbers calculated by the stepwise model extension with factors added with respect to decreasing VIP 
scores with (A) VIP > 1.6, (B,C) VIP > 1.3 and (D) VIP > 1.1.
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analysis indicated that, in contrast to previous reports, a minor impact of direct cell-cell interactions of HSPCs 
exists20,21,24,69.
Furthermore we also made an observation regarding material stiffness and HSPC expansion. The application 
of our new solvent-assisted micropatterning approach allowed us to demold very soft and fragile hydrogel micro-
structures in addition to our standard PDMS microstructures. As both hydrogels and PDMS exhibit distinct 
mechanical properties, we also tested the implementation of material stiffness into our mechanistic model. In 
contrast to recent reports, we did not observe that material stiffness (VIP < 0.8) affected HSPC expansion70.
In summary, our findings suggest that micron-sized spatial constraints allow for creating HSC microenviron-
ments with gradated functionality and impact on cell fate decisions. Functionalized microcavity arrays together 
with multiplex analysis and statistical analysis were proven useful to decipher specific signaling pathways of the 
dynamic regulation of HSPC. The introduced methodology can be applied to multiple related studies centering 
around the microenvironmental regulation of stem cells.
Methods
Fabrication of PDMS microcavity arrays. Fabrication of PDMS microcavity arrays was performed 
as described previously23. In brief, silicon masters were created with symmetric arrays of pillars, possessing a 
diameter of 15 or 40 μ m, a height of 10 μ m, and an intercolumniation of 3 μ m using photolithographic etching 
(GeSiM, Rossendorf, Germany). They were fluorosilanized via gas phase with (heptadecafluoro-1,1,2,2-tetrahy-
drodecyl)-dimethylchlorosilane (ABCR) prior to PDMS casting. PDMS microcavity arrays were created by repli-
cation of thin films of PDMS (Sylgard 184 silicone elastomer kit, Dow Corning, Wiesbaden, Germany) from the 
microstructured silicon wafers using a ratio of 10:1 for curing agent and prepolymer and curing at 120 °C for 2 h.
After curing, PDMS replicas were carefully peeled off the silicon master and unreacted prepolymer and curing 
agent were removed by swelling in heptane (Merck, Germany) for 24 h. Afterwards heptane was entirely removed 
by storage for 24 h in a vacuum oven at 60 °C, PDMS microcavity arrays were punched with a 11 mm punch press 
and attached on top of cleaned glass slides (Ø 11 mm). Subsequently the PDMS surfaces were treated with low 
pressure oxygen plasma (PDC-002, Harrick Plasma, NY, USA) for 60 s and incubated in a solution of 20 mM
3-aminopropyl-triethoxy-silane (ABCR) dissolved in ethanol (Sigma-Aldrich) for 2 h. After intense washing 
in ethanol and subsequent annealing for 1 h at 120 °C films of poly(ethylene-alt-maleic anhydride) (PEMA) (MW 
125000, Sigma-Aldrich) were produced by adding 40 μ L of a 0.3wt% solution of PEMA dissolved in ethanol on 
the amino-functionalized surface. PEMA was covalently linked to the surface by annealing at 120 °C for 2 h. 
Afterwards excess PEMA was removed by autoclaving in MilliQ for 20 min at 120 °C (autoclave system, DX23, 
Systec, Germany).
To covalently bind FN, the anhydride moieties on the surface of PEMA-coated PDMS microcavities were 
regenerated at 120 °C for 2 h and the microcavity arrays were incubated in 40 μ g·mL−1 FN (Roche, Germany) 
dissolved in phosphate buffered saline (PBS) (Sigma-Aldrich) for 1 h. Finally, surfaces were washed in PBS and 
CellGro® SCGM medium (CellGenix, Germany) prior to cell culture.
Fabrication of sPEG microcavity arrays. At first, sacrificial polystyrene (PS) microstructures were fab-
ricated via SAMIM71. Therefore, PDMS microstructures, embedded in polycarbonate holders (GeSiM), were 
molded (10:1 curing agent to prepolymer) from the microstructured silicon masters at 60 °C for 4 h and incorpo-
rated in a semiautomatic micro-contact-printing system (μ -CP 3.0, GeSiM). The PDMS membrane was wetted 
with 26 μ L of ethylacetate (Sigma-Aldrich), and immediately pressed into a flat PS sheet with a thickness of 400 
μ m (Evergreen Scale Models, Woodinville, WA, USA). After 15 min at 25 °C the PDMS pattern was carefully 
removed leaving a microstructured PS surface. The topography and dimensions of the patterned PS surfaces 
were analyzed via multi-pinhole confocal microscopy utilizing a μ surf explorer (NanoFocus AG, Oberhausen, 
Germany) equipped with a 60x objective (MoPlan APO 60x/0.9 Olympus Deutschland GmbH, Hamburg, 
Germany), providing a z-resolution of 2 nm and an x-y-resolution of 500 nm. Illustrated 3D maps were generated 
using μ Soft analysis software (NanoFocus AG).
Next glass coverslips were modified with a reactive maleic anhydride copolymer coating as described in detail 
by Pompe et al.72. Coverslips with a diameter of 11 mm (Menzel, Germany) were cleaned, oxidized in a solution 
of hydrogen peroxide (Merck, Darmstadt, Germany), ammonia (Fisher Scientific GmbH, Germany) and deion-
ized water (ratio of 1:1:5 (v/v/v)), and incubated for 2 h in a solution of 20 mM 3-aminopropyl-triethoxy-silane 
(ABCR, Karlsruhe, Germany) in isopropanol (Sigma-Aldrich, MO, USA) and deionized water (ratio of 9:1 
(v/v)). The amino-functionalized carriers were rinsed in isopropanol and annealed at 120 °C for 1 h. Thin films of 
poly(ethylene-alt-maleic anhydride) (PEMA) (MW 125000, Sigma-Aldrich) were produced by spincoating (RC5, 
Suess Microtec, Germany) 30 μ L of a 0.3wt% solution of PEMA dissolved in acetone and tetrahydrofuran (THF) 
(1:2 (v/v)) (both Sigma-Aldrich). The coverslips were treated at 120 °C for 2 h to covalently link the polymer film 
to the carrier. Excess polymer was removed by washing in acetone. Prior to immobilization of sPEG-heparin 
hydrogels, reactive anhydride groups of PEMA coated glass slides were created by treating for 2 h at 120 °C and 
in the following incubated in a solution of 100 μ g·mL-1 N-(2-Aminoethyl)maleimide (Sigma-Aldrich) dissolved 
in MilliQ. After 30 min of incubation the surfaces were rinsed with MilliQ and dried. Hydrogels were formed via 
maleimide-thiol Michael-type addition using a polymer content of 5 wt-% with a molar ratio of sPEG to heparin 
of approximately 2:1. Heparin (Merck-Millipore, Darmstadt, Germany) functionalized with 8 maleimide units 
per molecule (synthesized by M. Tsurkan, IPF Dresden) was dissolved in PBS and ultrasonicated for 1 min in 
ice-cooled water. At the same time thiol end-functionalized 4-arm sPEG was dissolved in PBS by ultrasonication 
and pH was adjusted to pH 5. In the case of pure sPEG hydrogels, maleimide end-functionalized 4-arm sPEG 
was used instead of heparin. A volume of 7.5 μ L of each thiol functionalized sPEG and heparin or maleimide 
functionalized sPEG solution was intensively mixed for 10 s. A volume of 14 μ L of the gel precursor solution was 
transferred to the surface of a maleimide functionalized PEMA-coated glass coverslips and the gel drop adhering 
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to the coverslip was placed on top of a microstructured PS surface. Next, hydrogels were allowed to form in the 
presence of the PS microstructures for 2 h at 22 °C. The PS microstructure was dissolved by immersion in xylene 
(Fluka, Germany). Solvent was exchanged three times after 1 h of incubation. Next the coverslip tethered hydro-
gels were washed with acetone, ethanol and PBS and left in PBS. Prior to cell culture, the gels were sterilized by 
washing with a solution of 0.02% ProClin® (Sigma-Aldrich) in PBS.
Isolation of human CD34+ cells from apharese blood. Granulocyte colony-stimulating factor (G-CSF) 
mobilized human HSPCs were immuno-magnetically isolated for CD34+ cells according to the manufacturer’s 
instructions (CD34 micro bead Kit UltraPure human, Miltenyi Biotec, Germany). All leukapheresis products 
were provided by the University Hospital Carl Gustav Carus, Dresden. Leukapheresis and subsequent cell exper-
iments were carried out in accordance to the approved guidelines of the ethics committee of the University 
Hospital Carl Gustav Carus Dresden including a written informed consent from healthy donors. Briefly, a sample 
of 2 mL leukapheresis blood was mixed with 4 mL ACK lysing buffer (Invitrogen, Germany) and incubated for 
5 min to lyse all red blood cells. Afterwards the sample was centrifuged at 300 g for 5 min (Sigma 4-16KS, Sigma 
Laborzentrifugen GmbH, Germany) and the supernatant was discarded. The remaining cell pellet was washed 
with 12 mL of isolation buffer (2 mM EDTA and 0.2% HSA in PBS) (both Sigma-Aldrich) and suspended in the 
staining solution containing 400 μ L FcR blocking agent, 400 μ L anti-human CD34-antibody (conjugated to 50 nm 
sized magnetic beads) and 1200 μ L isolation buffer. After incubation for 30 min at 4 °C, the samples were washed 
by the addition of 10 mL isolation buffer and centrifuged at 300 g for 5 min. Subsequently, cells were separated 
with a MACS® LS column (Miltenyi Biotec) attached to a MACS® separator (Miltenyi Biotec) retaining the mag-
netically labeled cells within the column. The flow through was discarded and the CD34+ cells were flushed in a 
5 mL isolation buffer after removal of the column from the magnetic field of the separator. To increase the purity 
of CD34+ cells, the procedure was repeated with a MACS® MS column subsequent to the first separation, and 
the magnetically captured CD34+ cells were flushed in 1.5 mL isolation buffer. Cell numbers and surface marker 
expression were measured with a MACSQuant Analyzer (Miltenyi Biotec).
Cell culture and analysis of human HSPCs on top of microcavity arrays. Cells were grown in 
serum-free CellGro® SCGM medium (CellGenix, Germany) supplemented with 10 or 30 ng·mL−1 of the growth 
factors SCF (Miltenyi Biotec), TPO and FLT3L (both R&D Systems, MN, USA). Prior to cell isolation, all scaf-
folds were pre-incubated in 48 suspension well plates (Fisher Scientific GmbH) for > 12 h in cell culture media 
without supplemented cytokines at 37 °C. For cell experiments, 500 μ L of cell suspensions containing either 30000 
or 60000 freshly isolated cells per mL were added on top of the hydrogel scaffolds. Between 2–3 microcavity 
samples were used per condition. Cells grown on TCP under the same conditions served as the control. After 7 
days in culture the supernatants, including non-adherent and adherent cells, were collected from the surfaces. 
Cells adhering to the FN functionalized microcavity scaffolds were detached using Accutase® (Thermo Electron 
Cooperation, Australia) (10 min at 37 °C), washed and resuspended. A portion of the harvested cells was used for 
live/dead cell staining with propidium iodide (PI) (Miltenyi Biotec) and counted with a MACSQuant Analyzer. 
The remaining cells were stained in PBS/5% (vol/vol) fetal calf serum (FCS; Biochrom, Berlin, Germany) and 
2 mM EDTA using CD34-FITC (clone: AC136) and CD133-APC (clone: 293C2) antibodies and cytometrically 
measured with MACSQuant Analyzer. Dead cells were excluded using PI. Obtained data were analyzed and pro-
cessed using FlowJo software (Tree Star Inc., OR, USA).
Secreted factor expression analysis in HSPC cultures. HSPC-secreted factors were measured using 
multiplex immunoassays based on the xMAP® technology (Luminex, TX, USA). Three different Bio-Plex Pro™ 
magnetic cytokine, chemokine, and growth factor assays were used: AngioPlex, 27-Plex and the TGF-β 3-Plex 
assay (BioRad, CA, USA). After 7 days of cell culture, the medium including all cells, was collected and centri-
fuged at 300 g for 5 min. Equal volumes of cell culture supernatants were stored at − 80 °C until analysis. After 
thawing 110–160 μ L aliquots from at least two donors per condition were transferred into a 96 protein low bind-
ing plate supported with 0.5% FCS. Samples were transferred in 50 μ L volumes into a Bio-Plex Pro™ 96 flat bot-
tom well plate (BioRad) and the assay procedures were performed according to the manufacturer´s instructions. 
Technical replicates were collected in parallel. Automated washing was performed using a Bio-Plex Pro™ wash 
station equipped with a magnet (BioRad). Finally, samples were analyzed via cytometric imaging with a Bio-Plex 
200 and analyzed with the Bio-Plex Manager™ Software, Standard Edition (both BioRad).
Partial least squares analysis of the mechanistic model. For partial least square (PLS) analysis of the 
mechanistic model, the software JMP® Pro (10.0.1.) and the software integrated NIPALS algorithm were used27. 
Obtained HSPC cell numbers were set as the y response and the measured growth factor levels, paracrine or auto-
crine signaling activities, adhesive as well as cell-cell interactions, and heparin content of the scaffolds were set as 
x variables. Values for the x variables were parameterized as shown in Fig. 3. Expecting dense hexagonal packing 
and considering empty and partially filled cavities, cell-cell interactions in the 40 μ m microcavity condition were 
parameterized assuming interactions from 9 of 12 maximal possible cells per cavity. Samples missing the concen-
tration of only one factor i, mostly caused by technical reasons, were completed by using the mean value of factor 
i calculated from all samples. Data were centered and scaled to have mean 0 and a standard deviation of 1. The 
optimum numbers of extracted factors were calculated applying the K-Fold cross validation method. The Van der 
Voet T2 test was applied to test whether models with different numbers of extracted factors differ significantly 
from the optimum model. Based on the results of the cross validation, the minimal numbers of latent factors 
were chosen to explain at least 90% of the variation of cumulative x and y variables and to not differ significantly 
from the optimum model by Van der Voet T2 tests. After determining the necessary number of latent factors, 
coefficients as well as the variable importance in the projection (VIP), a measure estimating the importance of a 
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variable in a PLS model, for each x variable were calculated. Subsequently, variables having a smaller VIP score 
than 0.8 were deleted from the model52. The optimized and VIP validated algorithm was tested to predict the 
HSPC numbers from the set of measured variables and compared with the counted cell numbers. Predicted and 
obtained cell numbers were plotted and a linear fit plus the coefficient of determination (R2) were calculated to 
validate the prediction of the algorithm.
Statistical Analysis. All data were analyzed using GraphPad Prism 6 (GraphPad Software Inc., USA) and 
JMP® Pro (10.0.1.). Analysis of the statistical significance between two samples was performed either by one-way 
ANOVA or two-way ANOVA (results obtained from at least two donors) and Tukey-Kramer’s post hoc test. 
Asterisk denote statistical significance as follows: * P < 0.05, * * P < 0.01, * * * P < 0.001. All data are presented as 
mean values ± standard deviation.
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